Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma: implications for targeted treatment.

Lambertz I, Kumps C, Claeys S, Lindner S, Beckers A, Janssens E, Carter DR, Cazes A, Cheung BB, De Mariano M, De Bondt A, De Brouwer S, Delattre O, Gibbons J, Janoueix-Lerosey I, Laureys G, Liang C, Marshall GM, Porcu M, Takita J, Camacho Trujillo D, Van Den Wyngaert I, Van Roy N, Van Goethem A, Van Maerken T, Zabrocki P, Cools J, Schulte JH, Vialard J, Speleman F, De Preter K.

Clin Cancer Res. 2015 Mar 24. pii: clincanres.2024.2014. [Epub ahead of print]

PMID:
25805801
2.

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.

Rihani A, De Wilde B, Zeka F, Laureys G, Francotte N, Tonini GP, Coco S, Versteeg R, Noguera R, Schulte JH, Eggert A, Stallings RL, Speleman F, Vandesompele J, Van Maerken T.

PLoS One. 2014 Dec 11;9(12):e114696. doi: 10.1371/journal.pone.0114696. eCollection 2014.

3.

MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.

Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL, Kaspers GJ, van Schie A, Kreissman SG, Yanik G, Hero B, Schmidt M, Laureys G, Lambert B, Øra I, Schulte JH, Caron HN, Tytgat GA.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):222-30. doi: 10.1007/s00259-014-2909-1. Epub 2014 Sep 30.

4.

β₂-adrenergic receptors protect axons during energetic stress but do not influence basal glio-axonal lactate shuttling in mouse white matter.

Laureys G, Valentino M, Demol F, Zammit C, Muscat R, Cambron M, Kooijman R, De Keyser J.

Neuroscience. 2014 Sep 26;277:367-74. doi: 10.1016/j.neuroscience.2014.07.022. Epub 2014 Jul 24.

PMID:
25064060
5.

Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.

Viprey VF, Gregory WM, Corrias MV, Tchirkov A, Swerts K, Vicha A, Dallorso S, Brock P, Luksch R, Valteau-Couanet D, Papadakis V, Laureys G, Pearson AD, Ladenstein R, Burchill SA.

J Clin Oncol. 2014 Apr 1;32(10):1074-83. doi: 10.1200/JCO.2013.53.3604. Epub 2014 Mar 3.

6.

β₂-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations.

Laureys G, Gerlo S, Spooren A, Demol F, De Keyser J, Aerts JL.

J Neuroinflammation. 2014 Jan 30;11:21. doi: 10.1186/1742-2094-11-21.

7.

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.

Cambron M, Mostert J, Haentjens P, D'Hooghe M, Nagels G, Willekens B, Heersema D, Debruyne J, Van Hecke W, Algoed L, De Klippel N, Fosselle E, Laureys G, Merckx H, Van Wijmeersch B, Vanopdenbosch L, Verhagen W, Hupperts R, Hengstman G, Michiels V, Van Merhaegen-Wieleman A, De Keyser J.

Trials. 2014 Jan 25;15:37. doi: 10.1186/1745-6215-15-37.

8.

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.

Rihani A, Van Maerken T, De Wilde B, Zeka F, Laureys G, Norga K, Tonini GP, Coco S, Versteeg R, Noguera R, Schulte JH, Eggert A, Stallings RL, Speleman F, Vandesompele J.

Pediatr Blood Cancer. 2014 Oct;61(10):1867-70. doi: 10.1002/pbc.24927. Epub 2014 Jan 4.

PMID:
24391119
9.

Emesis control by aprepitant in children and adolescents with chemotherapy.

Bauters TG, Verlooy J, Robays H, Benoit Y, Laureys G.

Int J Clin Pharm. 2013 Dec;35(6):1021-4. doi: 10.1007/s11096-013-9842-4. Epub 2013 Sep 4.

PMID:
24002338
10.

Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: A case report.

Colle I, Laureys G, Raevens S, Libbrecht L, Leroy JG, Reyntjens K, Geerts A, Rogiers X, Troisi RI, Hoehn H, Schindler D, Hanenberg H, De Wilde V, Van Vlierberghe H.

Hepatol Res. 2013 Sep;43(9):991-8. doi: 10.1111/hepr.12043. Epub 2013 May 15.

11.

Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.

Kumps C, Fieuw A, Mestdagh P, Menten B, Lefever S, Pattyn F, De Brouwer S, Sante T, Schulte JH, Schramm A, Van Roy N, Van Maerken T, Noguera R, Combaret V, Devalck C, Westermann F, Laureys G, Eggert A, Vandesompele J, De Preter K, Speleman F.

PLoS One. 2013;8(1):e52321. doi: 10.1371/journal.pone.0052321. Epub 2013 Jan 4.

12.

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Decock A, Ongenaert M, Hoebeeck J, De Preter K, Van Peer G, Van Criekinge W, Ladenstein R, Schulte JH, Noguera R, Stallings RL, Van Damme A, Laureys G, Vermeulen J, Van Maerken T, Speleman F, Vandesompele J.

Genome Biol. 2012 Oct 3;13(10):R95. doi: 10.1186/gb-2012-13-10-r95.

13.

Benign myelitis as a first presentation of systemic sarcoidosis: importance of early diagnosis and treatment.

Antoine S, Van Den Bossche B, Vandenhove J, De Braekeleer K, Laureys G.

Acta Neurol Belg. 2013 Mar;113(1):81-3. doi: 10.1007/s13760-012-0122-1. Epub 2012 Sep 14. No abstract available.

PMID:
22975831
14.

N-cadherin in neuroblastoma disease: expression and clinical significance.

Lammens T, Swerts K, Derycke L, De Craemer A, De Brouwer S, De Preter K, Van Roy N, Vandesompele J, Speleman F, Philippé J, Benoit Y, Beiske K, Bracke M, Laureys G.

PLoS One. 2012;7(2):e31206. doi: 10.1371/journal.pone.0031206. Epub 2012 Feb 15.

15.

Incidence, kinetics, and risk factors of Epstein-Barr virus viremia in pediatric patients after allogeneic stem cell transplantation.

Bordon V, Padalko E, Benoit Y, Dhooge C, Laureys G.

Pediatr Transplant. 2012 Mar;16(2):144-50. doi: 10.1111/j.1399-3046.2011.01634.x. Epub 2012 Jan 31.

PMID:
22288846
16.

White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.

Cambron M, D'Haeseleer M, Laureys G, Clinckers R, Debruyne J, De Keyser J.

J Cereb Blood Flow Metab. 2012 Mar;32(3):413-24. doi: 10.1038/jcbfm.2011.193. Epub 2012 Jan 4. Review.

17.

miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.

De Preter K, Mestdagh P, Vermeulen J, Zeka F, Naranjo A, Bray I, Castel V, Chen C, Drozynska E, Eggert A, Hogarty MD, Izycka-Swieszewska E, London WB, Noguera R, Piqueras M, Bryan K, Schowe B, van Sluis P, Molenaar JJ, Schramm A, Schulte JH, Stallings RL, Versteeg R, Laureys G, Van Roy N, Speleman F, Vandesompele J.

Clin Cancer Res. 2011 Dec 15;17(24):7684-92. doi: 10.1158/1078-0432.CCR-11-0610. Epub 2011 Oct 26.

18.

Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?

Garabedian L, Struyf S, Opdenakker G, Sozzani S, Van Damme J, Laureys G.

Eur Cytokine Netw. 2011 Sep;22(3):148-53. doi: 10.1684/ecn.2011.0290. Review.

PMID:
22001902
19.

The expression and role of CXC chemokines in colorectal cancer.

Verbeke H, Struyf S, Laureys G, Van Damme J.

Cytokine Growth Factor Rev. 2011 Oct-Dec;22(5-6):345-58. doi: 10.1016/j.cytogfr.2011.09.002. Epub 2011 Oct 14. Review.

PMID:
22000992
20.

Late onset painful cold-aggravated myotonia: three families with SCN4A L1436P mutation.

Bissay V, Keymolen K, Lissens W, Laureys G, Schmedding E, De Keyser J.

Neuromuscul Disord. 2011 Aug;21(8):590-3. doi: 10.1016/j.nmd.2011.05.006. Epub 2011 Jun 12.

PMID:
21664816
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk